| Source | ABC Local |
|---|---|
| Original Load Date | Sept. 4, 2026, 11 a.m. |
| Last Updated | Sept. 4, 2026, 11 a.m. |
| Original URL | https://abc7chicago.com/story/pancreatic-cancer-drug-may-hold-promise-lung-early-study-suggests/19789652/ |
Article Preview
A breakthrough drug [ recently approved to treat advanced pancreatic cancer
][14] may show promise against a specific type of lung cancer as well.
In an early phase clinical trial, researchers gave 136 patients with non-small
cell lung cancer daily doses of the drug, known as daraxonrasib, for thre...